Clinical Trial: A Study on the Efficacy and Safety of NALIRIFOX in Combination with Ivonescimab as First-Line Treatment for Locally Advanced or Metastatic Ampullary Cancer (China)

Posted On: 2026-11-12

China, Nov. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Efficacy and Safety of NALIRIFOX in Combination with Ivonescimab as First-Line Treatment for Locally Advanced or Metastatic Ampullary Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136490

Registration Time: 2026/11/11

Type: Interventional study

Primary Sponsor: West China Hospital of Sichuan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=351557

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A Study on the Efficacy and Safety of NALIRIFOX in Combination with Ivonescimab as First-Line Treatment for Locally Advanced or Metastatic Ampullary Cancer (China)